2013 Keynote Speakers
University of Wisconsin
Professor and MacArthur Foundation Fellow
Director of the Keck Center for Ghemical Genomics
Laura received her undergraduate training in Chemistry at the Massachusetts Institute of Technology. There she conducted undergraduate research in organic synthesis with Professor Bill Roush. She received her Ph.D. in Chemistry from Yale University where she worked with Stuart L. Schreiber on the synthesis of anti-tumor natural products. Her postdoctoral training at the California Institute of Technology in the research group of Peter B. Dervan led her to explore the recognition of duplex DNA through triple helix formation. She began her independent career in the Department of Chemistry at the University of Wisconsin-Madison in 1991.
Laura’s research group develops and implements synthetic methods to access biologically-active compounds for hypothesis-driven and discovery-driven research. This important foundation of our program offers chemically-oriented researchers new opportunities to develop and apply their synthetic skills. Biochemically- and biologically-oriented researchers benefit from access to unique biologically active ligands. Some representative questions that drive our interdisciplinary research program follow.
Laura was recently inducted into the National Academy of Sciences. Her honors and awards include a Guggenheim Fellowship, an ACS Frances P. Garvan-John M. Olin Medal, a Harrison-Howe Award, an Arthur C. Cope Scholar Awardand a Horrace S. Isabell Award.
Vice President, Chemistry and Distinguished Fellow
Peter Senter joined Seattle Genetics in August 1998 and has served as Vice President, Chemistry since September 2002. In February 2009, Dr. Senter was recognized as the company’s first Distinguished Fellow. He leads Seattle Genetics’ chemistry department, which carries out research in antibody-drug conjugate technologies, including the development of potent drug payloads, novel linker systems, conjugation methodology and mechanism of action studies. Prior to joining the company, Dr. Senter was with Cytokine Networks, Inc., the Bristol-Myers Squibb Pharmaceutical Research Institute and the Dana-Farber Cancer Institute, Harvard Medical School. Dr. Senter received a Ph.D. in Chemistry from the University of Illinois, and an A.B. in Biochemistry from the University of California, Berkeley. He is the Senior Editor of Bioconjugate Chemistry and serves on the Editorial Board of four scientific journals. Dr. Senter is an Affiliate Professor of Bioengineering at the University of Washington. His research interests include targeted drug delivery, protein chemistry and biochemistry, and anti-cancer drug design. Dr. Senter has authored more than 130 scientific publications and holds more than 40 patents.